Clinical Trial Update: Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease [Phase 3]

View source ↗

Summary

This Phase 3 trial update evaluates the safety and efficacy of natalizumab for Crohn's disease and notes that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED